<DOC>
	<DOCNO>NCT00726752</DOCNO>
	<brief_summary>This study design evaluate pharmacokinetics safety AG-013736 single dos multiple dos</brief_summary>
	<brief_title>A Study In Patients With Advanced Solid Tumor</brief_title>
	<detailed_description />
	<mesh_term>Axitinib</mesh_term>
	<criteria>Patients histologically cytologically diagnose advanced solid tumor Patients standard therapy effective , suitable therapy Eastern Cooperative Oncology Group ( ECOG ) Performance Status ( PS ) 0 , 1 2 Patients uncontrolled hypertension Patients central lung lesion involve major blood vessel Patients require anticoagulant therapy . Patients active epilepsy seizure symptom , brain metastasis require treatment , spinal cord compression carcinomatous meningitis .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>solid tumor</keyword>
	<keyword>Axitinib</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Phase 1</keyword>
</DOC>